Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Klener

Showing results (1-10 of 193) with videos related to

Pageof 20
Sort By:
Folia Biologica|April 3, 2012
Molecularly-targeted and biological anti-cancer therapyP Klener, P Klener
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 3, 2010
[ABL1, SRC and other non-receptor protein tyrosine kinases as new targets for specific anticancer therapy]P Klener, P Klener
Casopis Lekaru Ceskych|July 20, 1984
[High doses of cytosine arabinoside--a new use for an old drug]P Klener
Casopis Lekaru Ceskych|November 28, 1986
[Current possibilities and limitations of adjuvant chemotherapy]P Klener
Vnitrni Lekarstvi|February 1, 1983
[Modern treatment possibilities in non-Hodgkin's lymphoma]P Klener
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|March 3, 2010
[Angiogenesis as part of the tumor "ecosystem" and possibilities to influence it]P Klener
Casopis Lekaru Ceskych|January 3, 1994
[Present status in the development of new antineoplastic agents]P Klener
Casopis Lekaru Ceskych|January 3, 1986
[Risks of so-called non-orthodox methods in oncology]P Klener
Casopis Lekaru Ceskych|October 25, 1974
[Malignant lymphomas. II. Present therapeutic possibilities (author's transl)]P Klener
Casopis Lekaru Ceskych|April 21, 1978
[Combined chemotherapy in malignant tumours. Theoretical principles and general rules of practical use (author's transl)]P Klener
Pageof 20

Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
Folia Biologica|April 3, 2012
Molecularly-targeted and biological anti-cancer therapyP Klener, P Klener
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 3, 2010
[ABL1, SRC and other non-receptor protein tyrosine kinases as new targets for specific anticancer therapy]P Klener, P Klener
Casopis Lekaru Ceskych|July 20, 1984
[High doses of cytosine arabinoside--a new use for an old drug]P Klener
Casopis Lekaru Ceskych|November 28, 1986
[Current possibilities and limitations of adjuvant chemotherapy]P Klener
Vnitrni Lekarstvi|February 1, 1983
[Modern treatment possibilities in non-Hodgkin's lymphoma]P Klener
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|March 3, 2010
[Angiogenesis as part of the tumor "ecosystem" and possibilities to influence it]P Klener
Casopis Lekaru Ceskych|January 3, 1994
[Present status in the development of new antineoplastic agents]P Klener
Casopis Lekaru Ceskych|January 3, 1986
[Risks of so-called non-orthodox methods in oncology]P Klener
Casopis Lekaru Ceskych|October 25, 1974
[Malignant lymphomas. II. Present therapeutic possibilities (author's transl)]P Klener
Casopis Lekaru Ceskych|April 21, 1978
[Combined chemotherapy in malignant tumours. Theoretical principles and general rules of practical use (author's transl)]P Klener
Pageof 20